Interstitial Photodynamic Therapy During Standard Chemotherapy for Palliation of Patients With Head and Neck Squamous Cell Carcinoma - Phase II

Trial Profile

Interstitial Photodynamic Therapy During Standard Chemotherapy for Palliation of Patients With Head and Neck Squamous Cell Carcinoma - Phase II

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 May 2017

At a glance

  • Drugs Porfimer sodium (Primary)
  • Indications Head and neck cancer; Orofacial cancer; Oropharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2016 Status changed from recruiting to discontinued.
    • 02 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 17 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top